’ Consensus : Periodontitis and Atherosclerotic Cardiovascular Disease †

Dr. Friedewald has received honoraria for speaking from ovartis, East Hanover, New Jersey. Dr. Kornman is a ull-time employee and shareholder of Interleukin Genetics, altham, Massachusetts, which owns patents on genetic iomarkers for chronic inflammatory diseases. Dr. Genco is consultant to Merck. Dr. Ridker has received research upport from AstraZeneca, Wilmington, Delaware; Novaris; Pfizer, New York, New York; Roche, Nutley, New ersey; Sanofi-Aventis, Bridgewater, New Jersey; and Abott Laboratories, Abbott Park, Illinois. Dr. Ridker has eceived nonfinancial research support from Amgen, Thou-